These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6469761

  • 1. The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studies.
    Coleman CN, Hirst VK, Brown DM, Halsey J.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1381-6. PubMed ID: 6469761
    [Abstract] [Full Text] [Related]

  • 2. Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
    Coleman CN, Wasserman TH, Phillips TL, Strong JM, Urtasun RC, Schwade JG, Johnson RJ, Zagars G.
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(3-4):371-5. PubMed ID: 7107354
    [Abstract] [Full Text] [Related]

  • 3. Misonidazole with dexamethasone rescue: an escalating dose toxicity study.
    Tanasichuk H, Urtasun RC, Fulton DS, Raleigh J.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1735-7. PubMed ID: 6480455
    [Abstract] [Full Text] [Related]

  • 4. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
    Eifel PJ, Brown DM, Lee WW, Brown JM.
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
    [Abstract] [Full Text] [Related]

  • 5. The effect of nitroimidazoles on glucose utilization and lactate accumulation in mouse brain.
    Chao CF, Subjeck JR, Brody H, Shen J, Johnson RJ.
    Radiat Res; 1984 Jan; 97(1):87-96. PubMed ID: 6695046
    [Abstract] [Full Text] [Related]

  • 6. Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?
    Nelson DF, Gillespie BW, Diener MD, Davis DR, Wasserman T, Phillips TL, Stetz J.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1731-4. PubMed ID: 6384162
    [Abstract] [Full Text] [Related]

  • 7. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.
    Urtasun RC, Tanasichuk H, Fulton D, Agboola O, Turner AR, Koziol D, Raleigh J.
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(3-4):365-9. PubMed ID: 7107353
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G, Canal P, Mockey E, Vandevoorde E, Laurent F, Soula G.
    J Pharmacol; 1983 Sep; 14(1):67-77. PubMed ID: 6834852
    [Abstract] [Full Text] [Related]

  • 9. The effect of nitroimidazoles on the oxygen consumption rate and respiratory control ratio of beef heart mitochondria.
    Chao CF, Ting L, Subjeck JR, Johnson RJ.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1391-4. PubMed ID: 6469762
    [Abstract] [Full Text] [Related]

  • 10. Behavioural and ultrastructural studies of desmethylmisonidazole-induced neurotoxicity in mice.
    Chao CF, Subjeck JR, Johnson RJ.
    Br J Radiol; 1983 Jan; 56(661):27-31. PubMed ID: 6821740
    [Abstract] [Full Text] [Related]

  • 11. The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.
    Sheldon PW, Clarke C, Dawson KB.
    Br J Cancer; 1984 Feb; 49(2):207-13. PubMed ID: 6696821
    [Abstract] [Full Text] [Related]

  • 12. The neurotoxicity of radiosensitizing drugs: a biochemical assessment of desmethylmisonidazole (DMM) in the rat.
    Rose GP, Taylor JM.
    Toxicology; 1985 Jan; 34(1):43-56. PubMed ID: 3918357
    [Abstract] [Full Text] [Related]

  • 13. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
    Dische S, Saunders MI, Riley PJ, Hauck J, Bennett MH, Stratford MR, Minchinton AI.
    Br J Cancer; 1981 Mar; 43(3):344-9. PubMed ID: 7225285
    [Abstract] [Full Text] [Related]

  • 14. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
    McManus ME, Monks A, Collins JM, White R, Strong JM.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA, Workman P.
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of desmethylmisonidazole-induced neurotoxicity in the rat using brainstem auditory evoked potentials.
    Edwards MS, Gordon DG, Levin VA.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1377-9. PubMed ID: 6469760
    [Abstract] [Full Text] [Related]

  • 17. Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
    Hirst DG, Hazlehurst JL, Brown JM.
    Br J Cancer; 1984 Jan; 49(1):33-42. PubMed ID: 6229264
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
    Eifel PJ, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
    [Abstract] [Full Text] [Related]

  • 19. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging.
    Biskupiak JE, Grierson JR, Rasey JS, Martin GV, Krohn KA.
    J Med Chem; 1991 Jul; 34(7):2165-8. PubMed ID: 2066990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.